503 related articles for article (PubMed ID: 17064684)
1. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
2. Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ).
Krskova K; Filipcik P; Zilka N; Olszanecki R; Korbut R; Gajdosechova L; Zorad S
J Physiol Pharmacol; 2011 Aug; 62(4):403-10. PubMed ID: 22100841
[TBL] [Abstract][Full Text] [Related]
3. TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation.
Iwai M; Chen R; Imura Y; Horiuchi M
Am J Hypertens; 2007 May; 20(5):579-86. PubMed ID: 17485025
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats.
Takemori K; Inoue T; Ito H
Lipids Health Dis; 2013 Jul; 12():108. PubMed ID: 23876211
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.
Janke J; Schupp M; Engeli S; Gorzelniak K; Boschmann M; Sauma L; Nystrom FH; Jordan J; Luft FC; Sharma AM
J Hypertens; 2006 Sep; 24(9):1809-16. PubMed ID: 16915030
[TBL] [Abstract][Full Text] [Related]
6. Short term 13-cis-retinoic acid treatment at therapeutic doses elevates expression of leptin, GLUT4, PPARgamma and aP2 in rat adipose tissue.
Krskova-Tybitanclova K; Macejova D; Brtko J; Baculikova M; Krizanova O; Zorad S
J Physiol Pharmacol; 2008 Dec; 59(4):731-43. PubMed ID: 19212007
[TBL] [Abstract][Full Text] [Related]
7. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
[TBL] [Abstract][Full Text] [Related]
8. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
Tomono Y; Iwai M; Inaba S; Mogi M; Horiuchi M
Am J Hypertens; 2008 Feb; 21(2):206-12. PubMed ID: 18188158
[TBL] [Abstract][Full Text] [Related]
9. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
10. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
12. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
Pravdova E; Macho L; Fickova M
Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Jones ES; Black MJ; Widdop RE
J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
15. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551
[TBL] [Abstract][Full Text] [Related]
16. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
17. Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats.
Di Filippo C; Lampa E; Tufariello E; Petronella P; Freda F; Capuano A; D'Amico M
Obes Res; 2005 Nov; 13(11):1909-14. PubMed ID: 16339122
[TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
[TBL] [Abstract][Full Text] [Related]
20. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats.
Gohlke P; Von Kügelgen S; Jürgensen T; Kox T; Rascher W; Culman J; Unger T
J Hypertens; 2002 May; 20(5):909-18. PubMed ID: 12011652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
